Holen Sie sich die Stockscreener-App
87.26
0.39%
0.34
Handel nachbörslich:
87.26
Schlusskurs vom Vortag:
$86.92
Offen:
$86.82
24-Stunden-Volumen:
202.71K
Relative Volume:
1.19
Marktkapitalisierung:
$1.98B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
47.68
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-2.55%
1M Leistung:
-0.67%
6M Leistung:
+10.88%
1J Leistung:
-9.43%
1-Tages-Spanne:
$86.58
$90.00
1-Wochen-Bereich:
$84.41
$90.51
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
87.26 | 1.97B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
538.82 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.04 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.19 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.40 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
286.94 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder value2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
Is LeMaitre Vascular Inc. stock a safe buy before earningsJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Using Bollinger Bands to evaluate LeMaitre Vascular Inc.July 2025 Levels & AI Based Buy and Sell Signals - newser.com
Will earnings trigger a reversal in LeMaitre Vascular Inc.Quarterly Market Review & Daily Price Action Insights - newser.com
LeMaitre Vascular, Inc. $LMAT Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
Will LeMaitre Vascular Inc. (LHU) stock keep high P E multiples2025 Price Momentum & Weekly High Return Forecasts - newser.com
Applying Elliott Wave Theory to LeMaitre Vascular Inc.Oil Prices & Weekly Top Gainers Trade List - newser.com
Why analysts remain bullish on LeMaitre Vascular Inc. stockRisk Management & Consistent Income Trade Recommendations - newser.com
LeMaitre Vascular Inc. stock momentum explainedPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
Will LeMaitre Vascular Inc. (LHU) stock beat Nasdaq index returns2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Is LeMaitre Vascular Inc. stock ready for a breakoutJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
What hedge fund moves indicate for LeMaitre Vascular Inc. (LHU) stockEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-11-03 05:32:52 - newser.com
What catalysts could drive LeMaitre Vascular Inc. stock higherJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Will LeMaitre Vascular Inc. stock remain a Wall Street favoriteWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Geneva Capital Management LLC Has $76.01 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
How to read the order book for LeMaitre Vascular Inc.Inflation Watch & Safe Entry Point Identification - newser.com
What technical patterns form on LeMaitre Vascular Inc. (LHU) stock chartsJuly 2025 Opening Moves & Capital Protection Trade Alerts - newser.com
Is LeMaitre Vascular Inc LHU a good long term investmentStock Buy Signals & Superior Growth Investment - earlytimes.in
Will LeMaitre Vascular Inc. stock attract more institutional investorsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LeMaitre Vascular, Inc. (LMAT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Press Releases about LeMaitre Vascular, Inc.Common Stock - FinancialContent
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Published on: 2025-10-30 01:49:16 - newser.com
LeMaitre Vascular (LMAT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will LeMaitre Vascular Inc. stock benefit from green energy trendsJuly 2025 Rallies & Daily Price Action Insights - newser.com
LeMaitre Vascular, Inc. (LMAT) Stock forecasts - Yahoo! Finance UK
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):